Abstract
MODERATE non-progressive cognitive impairment is a consistent feature of Duchenne muscular dystrophy (DMD)1,2, although no central nervous system (CNS) abnormality has been identified3. Recent studies have elucidated the molecular defect in DMD, including the absence of the protein dystrophin in affected individuals4. Normal brain tissue contains dystrophin messenger RNA5,6 and dystrophin is present in low abundance in the brain7 and seems to be regulated in this tissue, at least in part, by a promoter that differs from that in muscle8,9. Until now, antibodies and immunocytochemical methods used to demonstrate dystrophin at the plasma membrane of mouse and human muscle have proven inadequate to localize precisely dystrophin in the mammalian CNS. We have now made an antibody (anti 6-10) which is much more sensitive than those previously available to immunolabel dystrophin in the CNS. Using this antibody, we found that in the mouse, dystrophin is particularly abundant in the neurons of the cerebral and cerebellar cortices, and that it is localized at postsynaptic membrane specializations. Dystrophin may have a different role in neurons than in muscle, and an alteration at the synaptic level may be the basis of the cognitive impairment in DMD.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Duchenne, G. B., in De I'Electrisation Localisée et son Application á la Pathologie et á la Therapeutique 3rd edn (Bailliere, Paris, 1872).
Emery, A. H. in Duchenne Muscular Dystrophy Revised edn, 99–100 (Oxford University Press, New York, 1988).
Dubowitz, V. & Crome, L. Brain 92, 805–808 (1969).
Hoffman, E. P. & Kunkel, L. M. Neuron 2, 1019–1029 (1989).
Nudel, U., Robzyk, K. & Yaffe, D. Nature 331, 635–638 (1988).
Chamberlain, J. S. et al. Science 239, 1416–1418 (1988).
Hoffman, E. P., Hudecki, M. S., Rosenberg, P. A., Pollina, C. M. & Kunkel, L. M. Neuron 1, 411–420 (1988).
Feener, C. A., Koenig, M. & Kunkel, L. M. Nature 338, 509–511 (1989).
Boyce, F. M., Beggs, A. H., Feener, C. A. & Kunkel, L. M. Proc. natn. Acad. Sci. U.S.A. (in the press).
Hoffman, E. P., Brown, R. H. & Kunkel, L. P. Cell 51, 919–928 (1987).
Koenig, M., Monaco, A. P. & Kunkel, L. P. Cell 53, 219–228 (1988).
Coleman, T. R., Fishkind, D. J., Mooseker, M. S. & Morrow, J. S. Cell Motll Cytoskel. 12, 225–247 (1989).
Beam, K. G. Nature 333, 798 (1988).
Chang, H. W., Bock, E. & Bonilla, E. J. biol. Chem. 264, 20831–20834 (1989).
Bulfield, G., Siller, W. G., Wight, P. A. L. & Moore, K. J. Proc. natn. Acad. Sci. U.S.A. 81, 1189–1192 (1984).
Marin-Padilla, M. J. comp. Neurol. 167, 63–81 (1985).
Purpura, D. P. in Brain Mechanisms in Mental Retardation (eds Buchwald, N. A. & Brazer, M. B. D.) 141–169 (Academic, New York, 1985).
Suetsugu, M. & Mahraein, P. Acta neuropath. 50, 207–210 (1980).
Takashima, S., Becker, L. E., Armstrong, D. L. & Chan, F. Brain Res. 225, 1–21 (1981).
Laemmli, U. K. Nature 227, 680–685 (1970).
Smith, D. B. & Johnson, K. S. Gene 67, 31–40 (1988).
Byers, T. J., Dubreuil, R., Branton, D., Kiehart, D. P. & Goldstein, L. S. B. J. Cell Biol. 105, 2103–2110.
Grzanna, R. in Techniques in Immunocytochemistry Vol. 1 (ed. Bullock, G. R. & Petrusz, P.) 183–204 (Academic, New York, 1982).
Watkins, S. C., Samuel, J. L., Marotte, F., Bertier-Savalle, B. & Rappaport, L. Circulation Res. 60, 327–336 (1987).
Watkins, S. C., Hoffman, E. P., Slayter, H. S. & Kunkel, L. M. Nature 333, 863–866 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lidov, H., Byers, T., Watkins, S. et al. Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons. Nature 348, 725–728 (1990). https://doi.org/10.1038/348725a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/348725a0
This article is cited by
-
Febuxostat ameliorates muscle degeneration and movement disorder of the dystrophin mutant model in Caenorhabditis elegans
The Journal of Physiological Sciences (2023)
-
Dystrophin Short Product, Dp71, Interacts with AQP4 and Kir4.1 Channels in the Mouse Cerebellar Glial Cells in Contrast to Dp427 at Inhibitory Postsynapses in the Purkinje Neurons
Molecular Neurobiology (2023)
-
Generation of dystrophin short product-specific tag-insertion mouse: distinct Dp71 glycoprotein complexes at inhibitory postsynapse and glia limitans
Cellular and Molecular Life Sciences (2022)
-
Specific Dystrophins Selectively Associate with Inhibitory and Excitatory Synapses of the Mouse Cerebellum and their Loss Alters Expression of P2X7 Purinoceptors and Pro-Inflammatory Mediators
Cellular and Molecular Neurobiology (2022)
-
Motor axonopathies in a mouse model of Duchenne muscular dystrophy
Scientific Reports (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.